tiprankstipranks
Trending News
More News >
HCA Healthcare (HCA)
NYSE:HCA
US Market

HCA Healthcare (HCA) Earnings Dates, Call Summary & Reports

Compare
1,768 Followers

Earnings Data

Report Date
Apr 24, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
7.17
Last Year’s EPS
6.45
Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Jan 27, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong operational execution and financial results (double‑digit EBITDA growth, record patient encounters, robust cash flow, aggressive buybacks/dividend increase and stable margin guidance) while explicitly identifying sizable, policy-driven headwinds (expired exchange subsidies, lower supplemental payments, uninsured exposure and labor/physician cost pressures). Management presented a detailed resiliency program ($400M target) and digital initiatives intended to offset much of the exchange impact and reiterated confidence in delivering within long-term plans. Net: solid corporate momentum and balance-sheet strength tempered by meaningful near-term reimbursement and policy uncertainty.
Company Guidance
HCA’s 2026 guidance called for revenue of $76.5–80.0 billion, adjusted EBITDA of $15.55–16.45 billion, net income attributable of $6.5–7.0 billion and adjusted diluted EPS of $29.01–31.50, with equivalent admissions growth of 2–3% and full‑year adjusted EBITDA margin slightly above 20%; cash flow from operations of $12–13 billion and capital spending raised to $5.0–5.5 billion; management expects an adverse exchange‑related EBITDA impact of $600–900 million (reflecting 2025 administrative reforms and EPTC expiration) partially offset by roughly $400 million of resiliency savings, and a $250–450 million decline in supplemental payment net benefit (with the Texas pause ~one‑third of that change and Virginia/Tennessee items noted); no material incremental hurricane‑market EBITDA vs. prior year; balance‑sheet leverage at the low end of target; a new $10 billion share‑repurchase authorization (majority of the prior program expected to be completed in 2026) and a quarterly dividend increase to $0.78; assumptions discussed include a modeled 15–20% decline in exchange volumes (15–20% of that migrating to employer coverage) and ~30% lower utilization for those becoming uninsured.
Strong Revenue and Profit Growth
Revenue increased 6.7% versus prior year quarter; adjusted EBITDA grew ~11% in the quarter and 12.1% for the full year; adjusted EBITDA margin improved ~80 bps in the quarter and 90 bps for the year; net income attributable to HCA increased ~31% and adjusted diluted EPS rose ~29%.
Record Patient Activity and Consistent Volume Growth
Company recorded ~47 million patient encounters for the year (a record) and reported the nineteenth straight quarter of volume growth; same-facility admissions increased ~2.4% and equivalent admissions increased ~2.4%-2.5% (quarter and full year figures consistent with 2%-3% long-term range).
Cash Flow, Capital Allocation and Shareholder Returns
Operating cash flow of $2.4B in the quarter and $12.6B for the year (a 20% YoY increase); FY capital expenditures $4.9B; share repurchases $2.6B in the quarter and $10B for the year; board authorized a new $10B repurchase program and raised the quarterly dividend from $0.72 to $0.78.
2026 Financial Guidance Reflects Resilience
2026 guidance: revenues $76.5B–$80.0B; adjusted EBITDA $15.55B–$16.45B; net income $6.5B–$7.0B; adjusted diluted EPS $29.01–$31.50; full-year margins expected slightly above 20%; cash flow from operations expected $12B–$13B.
Operational Improvements and Resiliency Program
Management highlighted disciplined expense management, improved labor results and other operating expense improvements driving margin expansion; resiliency program is expected to deliver approximately $400M of incremental savings in 2026 through revenue integrity, cost efficiencies, capacity management and digital/AI initiatives.
Investments in Network, Outpatient Footprint and Technology
Significant investments in network expansion, workforce, clinical capabilities and AI/tech (EHR transition underway); added ~100 outpatient business units during the year (company now ~2,700 outpatient facilities) and increased 2026 capex range to $5.0B–$5.5B to support growth.
Improved Working Capital and Revenue Cycle Progress
Notable reduction in net days in accounts receivable in Q4 attributed in part to digital integration with payers; digital engagements expected to improve claims timeliness, reduce denials and support collections.

HCA Healthcare (HCA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

HCA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 24, 2026
2026 (Q1)
7.17 / -
6.45
Jan 27, 2026
2025 (Q4)
7.46 / 8.01
6.2228.78% (+1.79)
Oct 24, 2025
2025 (Q3)
5.79 / 6.96
4.942.04% (+2.06)
Jul 25, 2025
2025 (Q2)
6.29 / 6.84
5.524.36% (+1.34)
Apr 25, 2025
2025 (Q1)
5.75 / 6.45
5.3620.34% (+1.09)
Jan 24, 2025
2024 (Q4)
6.13 / 6.22
5.95.42% (+0.32)
Oct 25, 2024
2024 (Q3)
4.96 / 4.90
3.9125.32% (+0.99)
Jul 23, 2024
2024 (Q2)
4.93 / 5.50
4.2928.21% (+1.21)
Apr 26, 2024
2024 (Q1)
5.06 / 5.36
4.938.72% (+0.43)
Jan 30, 2024
2023 (Q4)
5.05 / 5.90
4.6427.16% (+1.26)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HCA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jan 27, 2026
$472.38$505.84+7.08%
Oct 24, 2025
$439.51$446.38+1.56%
Jul 25, 2025
$340.36$333.23-2.10%
Apr 25, 2025
$339.63$326.21-3.95%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does HCA Healthcare (HCA) report earnings?
HCA Healthcare (HCA) is schdueled to report earning on Apr 24, 2026, Before Open (Confirmed).
    What is HCA Healthcare (HCA) earnings time?
    HCA Healthcare (HCA) earnings time is at Apr 24, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HCA EPS forecast?
          HCA EPS forecast for the fiscal quarter 2026 (Q1) is 7.17.

            HCA Healthcare (HCA) Earnings News

            HCA Recovers from $200 Million Hurricane Hit to Beat Q4 Forecasts
            Premium
            Market News
            HCA Recovers from $200 Million Hurricane Hit to Beat Q4 Forecasts
            1y ago
            HCA Healthcare Delivers Mixed Results in Q3
            Premium
            Market News
            HCA Healthcare Delivers Mixed Results in Q3
            3y ago
            Here’s Why HCA Healthcare Shares Rose 11.4%
            Premium
            Market News
            Here’s Why HCA Healthcare Shares Rose 11.4%
            4y ago